Immunologic Agents : Active Immunity (Vaccines and Toxoids)
IHAVR3 “Havrix 1440 Junior injection” 50 U/ml; 1 ml/vial
IVAQT1 “Vaqta injection” 25 U/ml; 0.5 ml/vial
適應症：預防A型肝炎。
Usual dose:
Adult (≥ 19 yrs): IM
A single 1 ml dose and a booster dose of 1 ml 6 mon later.
Pediatric (1-18 yrs): IM
A single 0.5 ml dose and a booster dose of 0.5 ml 6-18 mon later.
Precaution:
P’ts with malignancies or those receiving immunosuppressive therapy or immunocompromised p’ts, acute infections or febrile illness.
Adverse effect:
Pain, tenderness and swelling at inj. site, warmth, erythema, ecchymosis, abdominal pain, diarrhoea, vomiting, headache, pharyngitis.
Related Entries
(Visited 24 times, 1 visits today)